Author:
Shiozawa Jun,de Vega Susana,Yoshinaga Chiho,Ji Xang,Negishi Yoshifumi,Momoeda Masahiro,Nakamura Tomomi,Yoshida Hiroyuki,Kaneko Haruka,Ishijima Muneaki,Okada Yasunori
Abstract
AbstractDestruction of articular cartilage in osteoarthritis (OA) is initiated by depletion of the hyaluronan (HA)-aggrecan network, followed by degradation of the collagen fibrils. Previously, we reported the implications of HA-binding protein involved in HA depolymerization (HYBID), alias cell migration-inducing protein (CEMIP) and KIAA1199, for HA degradation. However, transmembrane protein 2 (TMEM2), which is ~ 50% homologous to HYBID, was discovered as another hyaluronidase, but their expression and regulation by OA chondrocytes remain elusive. Here we report that the absolute mRNA copy numbers of HYBID are significantly (7.1-fold) higher in OA cartilage than normal cartilage, whereas TMEM2 levels are not different between the groups. HA-degrading activity of cultured OA chondrocytes disappeared by siRNA-mediated knockdown of HYBID, but not TMEM2. HYBID expression was significantly up-regulated by treatment with interleukin-6 (IL-6) or tumor necrosis factor-α (TNF-α) and additively increased by the combined treatment. No significant changes in the TMEM2 expression were seen by the factors examined. IL-1α remarkably enhanced IL-6 production and increased HYBID expression when soluble IL-6 receptor was supplemented. These results demonstrate that in stark contrast to the constitutive expression of TMEM2 and its negligible HA-degrading activity, HYBID is overexpressed in OA cartilage and up-regulated by IL-6 and TNF-α in OA chondrocytes.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Okada, Y. Proteinases and matrix degradation 10th edn, In: Firestein, GS. Budd, RC. Gabriel, SE. McInnes, IB, O’Dell JR (eds.), Kelley and Firestein’s Textbook of Rheumatology. pp. 106–125. (Elsevier Inc., Philadelphia, USA, 2017)
2. Primorac, D. et al. Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations. Genes 11, 854. https://doi.org/10.3390/genes11080854 (2020).
3. Fosang, A. J. & Little, C. B. Drug insight: Aggrecanases as therapeutic targets for osteoarthritis. Nat. Clin. Pract. Rheumatol. 4, 420–427. https://doi.org/10.1038/ncprheum0841 (2008).
4. Csoka, A. B., Frost, G. I. & Stern, R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20, 499–508. https://doi.org/10.1016/s0945-053x(01)00172-x (2001).
5. Yoshida, H. et al. KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. Proc. Natl. Acad. Sci. USA 110, 5612–5617. https://doi.org/10.1073/pnas.12154321101215432110[pii] (2013).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献